innerbuddies gut microbiome testing

Gut Microbiome & Metabolic Syndrome: Prediabetes Link, Causes & Solutions

Your gut microbiome is more than a digestive community—it helps regulate inflammation, insulin sensitivity, bile acid metabolism, and how efficiently your body processes carbohydrates. When metabolic syndrome and prediabetes develop, the gut ecosystem often shifts toward a lower-diversity pattern, with changes in “good” and “harmful” microbes that can promote metabolic stress rather than metabolic resilience.

Research links dysbiosis (microbial imbalance) to key drivers of prediabetes, including impaired gut barrier function (“leaky gut”), higher inflammatory signaling, and altered production of short-chain fatty acids (SCFAs) like butyrate. SCFAs support healthy glucose metabolism by improving gut integrity and influencing hormones involved in appetite and insulin response. In metabolic syndrome, changes in diet, sleep, stress, and body fat distribution can further disrupt microbial balance, creating a cycle that makes blood sugar harder to manage.

The good news: microbiome-focused strategies can complement traditional lifestyle and medical approaches. By targeting fiber intake, gut-friendly carbohydrates, fermented foods, and lifestyle factors that shape microbial composition (activity, stress reduction, and adequate sleep), you may improve insulin sensitivity and support healthier metabolic signaling. This guide breaks down the most important gut microbiome mechanisms behind prediabetes and offers evidence-based, actionable steps to help you move toward better blood sugar control.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Metabolic syndrome with prediabetes

Metabolic syndrome with prediabetes is a common cluster of risk factors—elevated fasting glucose, central adiposity, dyslipidemia, and high blood pressure—that raises the risk of progression to type 2 diabetes and cardiovascular disease. Recent research highlights the gut microbiome as a key modulator of metabolic health, where dysbiosis can contribute to insulin resistance and chronic inflammation through leaky gut, altered metabolite production, and disrupted bile acid signaling. Diet patterns rich in ultra-processed foods and low in diverse fiber, along with stress and poor sleep, can worsen this gut–metabolic imbalance.

Mechanistically, dysbiosis reduces short-chain fatty acid production that supports gut barrier function and insulin sensitivity, weakens the gut mucus layer, and shifts energy harvest and inflammatory signaling. Microbial changes also reshape bile acid pools, affecting receptors like FXR and TGR5 that regulate glucose handling, energy metabolism, and inflammation. Together, these gut-driven processes drive higher fasting glucose, elevated HbA1c, central adiposity, and the cardiometabolic risk profile seen in metabolic syndrome with prediabetes.

Testing the gut microbiome offers a practical, personalized lens on this condition by revealing patterns of dysbiosis, fermentation potential for SCFAs, and bile acid signaling tendencies. Results can guide targeted nutrition—emphasizing diverse fiber, prebiotics, and tolerated fermented foods—to bolster beneficial microbes and improve glycemic control and lipid markers. Programs like InnerBuddies describe how microbiome results map onto insulin resistance risk and cardiometabolic signals, helping tailor fiber type and timing to support a healthier gut environment and slower progression toward diabetes.

  • Preserve SCFA-producing gut microbes (Faecalibacterium prausnitzii; Roseburia spp.; Eubacterium rectale; Anaerostipes spp.; Coprococcus spp.; Bifidobacterium spp.) to strengthen gut barrier and improve insulin sensitivity.
  • Support Akkermansia muciniphila and related Bacteroides (e.g., Bacteroides uniformis) for mucosal health and favorable glucose/lipid metabolism.
  • Limit expansion of pro-inflammatory pathobionts (Enterococcus spp.; Streptococcus spp.; Escherichia/Shigella; Klebsiella spp.; Bilophila wadsworthia; Desulfovibrio spp.) to reduce systemic inflammation and insulin resistance.
  • Dysbiosis-driven changes in bile acid signaling (FXR/TGR5) contribute to worsened glucose control and cardiometabolic risk.
  • A high-fiber, minimally processed diet supports beneficial taxa and SCFA production, helping reduce central adiposity and improve HbA1c.
  • Microbiome testing can guide personalized nutrition by showing whether your gut favors SCFA production or dysbiosis, informing fiber type and amount.
Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Metabolic syndrome

Metabolic syndrome with prediabetes refers to a cluster of risk factors—including higher blood sugar, excess abdominal fat, abnormal cholesterol/triglyceride levels, and elevated blood pressure—that tend to occur together and raise the risk of developing type 2 diabetes and cardiovascular disease. Prediabetes typically involves elevated fasting glucose and/or impaired glucose tolerance, often driven by insulin resistance. In recent years, the gut microbiome has emerged as an important modulator of metabolic health, influencing how the body regulates inflammation, energy extraction from food, bile acid signaling, and glucose metabolism.

Research suggests that dysbiosis (an imbalance in gut microbial composition and function) may contribute to insulin resistance through several pathways: increased gut permeability (“leaky gut”) that can promote low-grade inflammation; production of less beneficial metabolites (like short-chain fatty acids) that normally support gut barrier integrity and insulin sensitivity; altered fermentation and fiber utilization; and changes in bile acid profiles that affect metabolic signaling via receptors such as FXR and TGR5. Diet patterns that are high in ultra-processed foods and low in diverse fiber can further weaken microbiome resilience, while chronic stress and poor sleep may amplify inflammatory signaling and worsen metabolic outcomes.

The good news is that gut-focused, evidence-based interventions can complement standard prediabetes and metabolic syndrome strategies. Diet quality—especially increasing non-starchy vegetables, legumes, whole grains, nuts, seeds, and a variety of fibers—can help restore beneficial microbes and boost short-chain fatty acid production. Targeted foods that support microbial diversity (prebiotic fibers like inulin/FOS, and fermented options such as yogurt or kefir if tolerated) may improve glycemic control markers in some people. Alongside nutrition, regular physical activity, weight management, adequate sleep, and limiting alcohol and excess added sugars can strengthen insulin sensitivity and reduce inflammation—supporting a gut environment more conducive to healthier metabolism.

  • Elevated fasting blood glucose
  • Higher-than-normal HbA1c (prediabetes range)
  • Insulin resistance (trouble regulating blood sugar after meals)
  • Increased abdominal fat / central weight gain
  • Unfavorable cholesterol or triglycerides (e.g., high triglycerides, low HDL)
  • Hypertension (higher blood pressure)
Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Metabolic syndrome with prediabetes

This is relevant for people who have been told they have metabolic syndrome and prediabetes, especially if their labs show higher fasting glucose and/or elevated HbA1c in the prediabetes range, along with signs of insulin resistance. It’s also a good fit for those who notice patterns of blood-sugar difficulty after meals (e.g., feeling unusually hungry, tired, or “shaky” when they eat), which often tracks with impaired glucose regulation and may be influenced by gut–immune and metabolic signaling.

It’s particularly relevant if your metabolic risk factors cluster together—such as increased abdominal/central weight gain, abnormal triglycerides (often high), low HDL, and/or elevated blood pressure. Since the gut microbiome can affect inflammation, bile acid signaling, and how your body extracts and processes energy from food, people with these combined cardiometabolic markers may benefit from a gut-focused approach alongside standard lifestyle measures.

It may also be especially helpful if you’ve tried conventional recommendations but still struggle with ongoing low-grade inflammation, difficulty improving glucose markers, or maintaining dietary consistency. This is relevant for people whose diets are low in diverse fiber and higher in ultra-processed foods, and for those experiencing stress and poor sleep—both of which can promote gut dysbiosis and weaken the gut barrier, potentially worsening insulin sensitivity and triglycerides. A strategy that emphasizes microbiome-supporting foods (non-starchy vegetables, legumes, whole grains, nuts/seeds, and fermented or prebiotic fibers if tolerated) aligns with these underlying drivers.

Metabolic syndrome and prediabetes are extremely common in adults, largely because both are strongly linked to insulin resistance and abdominal (central) weight gain—patterns that often show up together as overlapping cardiometabolic risk. In the United States, about 1 in 3 adults meet criteria for metabolic syndrome (roughly 35% overall, with higher rates in midlife and among those with obesity). Prediabetes is also widespread: approximately 1 in 3 adults in the U.S. have prediabetes (around 88 million people; ~38%), defined by elevated fasting glucose and/or impaired glucose tolerance and/or higher-than-normal HbA1c, which matches the “elevated fasting blood glucose” and “higher-than-normal HbA1c” features described.

Globally, the prevalence is similarly high, though estimates vary by country, diagnostic criteria, and age structure. Across many high- and middle-income countries, prediabetes affects roughly 20–50% of adults, and metabolic syndrome prevalence is often reported in the ~20–40% range. Because the driver is commonly insulin resistance plus visceral adiposity, the symptom pattern you listed—central weight gain, unfavorable lipids (such as high triglycerides and low HDL), and hypertension—frequently clusters in the same individuals, contributing to why the two conditions are seen together so often.

Importantly, the transition from prediabetes to type 2 diabetes remains a major public health issue, with many people persisting in the prediabetic range for years before progression (and a smaller fraction reverting to normoglycemia). With typical progression estimates of roughly 5–10% per year developing type 2 diabetes from prediabetes, the large underlying pool of adults with prediabetes and metabolic syndrome means the combined burden is substantial. This is also the population most likely to show microbiome-associated metabolic features—low-grade inflammation and impaired gut-barrier function—supporting the relevance of gut-focused risk reduction strategies for a very large share of adults.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Gut Microbiome & Metabolic Syndrome: Prediabetes Link, Causes & Solutions

Metabolic syndrome with prediabetes is closely tied to gut microbiome changes because many underlying drivers—insulin resistance, low-grade inflammation, and altered bile acid signaling—can be influenced by microbial composition and function. When the gut ecosystem shifts toward “dysbiosis,” it may contribute to a more inflammatory environment that interferes with how the body processes glucose, supporting higher fasting glucose and HbA1c levels. Dysbiosis can also affect the integrity of the gut barrier, which may promote increased intestinal permeability and help sustain chronic, subtle inflammation.

Microbial metabolite output is another key connection. Beneficial gut bacteria help produce short-chain fatty acids (SCFAs) from dietary fiber; SCFAs support gut barrier strength, modulate immune signaling, and improve insulin sensitivity. When diets are low in diverse fibers (and higher in ultra-processed foods), SCFA production and microbial diversity can decline, which may worsen glucose regulation and contribute to insulin resistance and central weight gain. These same diet-pattern changes can also influence fermentation balance and the gut’s ability to process energy, potentially affecting triglycerides and HDL.

Finally, gut microbes can alter bile acid profiles, which act as metabolic signals through receptors like FXR and TGR5 that regulate glucose handling, inflammation, and energy metabolism. An unfavorable bile acid balance may therefore worsen blood sugar control and cardiometabolic risk markers such as blood pressure and lipid abnormalities. Improving the gut environment with fiber-rich, minimally processed foods (vegetables, legumes, whole grains, nuts, seeds) and, when tolerated, prebiotic fibers and fermented dairy/alternatives can help restore microbial diversity and metabolite production—supporting healthier metabolic signaling and potentially improving prediabetes-related parameters.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Gut Microbiome and Metabolic syndrome with prediabetes

  • Insulin resistance via dysbiosis-driven inflammation: Gut microbial imbalance can promote low-grade systemic inflammation (e.g., altered immune signaling, endotoxin-related pathways) that impairs insulin signaling and worsens fasting glucose and HbA1c.
  • Reduced SCFA production from low-fiber diets: Less microbial fermentation of dietary fiber decreases short-chain fatty acids (acetate/propionate/butyrate), which normally support gut barrier function, modulate immune responses, and improve insulin sensitivity.
  • Increased intestinal permeability (“leaky gut”): Dysbiosis can weaken tight junctions and the mucus layer, allowing microbial components to cross the gut barrier and sustain chronic inflammation that contributes to metabolic dysfunction.
  • Altered bile acid metabolism and signaling: Microbes modify bile acid composition, influencing FXR and TGR5 receptors that regulate glucose homeostasis, energy metabolism, and inflammatory tone.
  • Changes in gut energy harvest and metabolite signaling: Shifts in microbial pathways can affect how calories and metabolites are processed, potentially contributing to central fat gain, dyslipidemia, and worsening cardiometabolic risk markers.
  • Impaired gut–liver–metabolic axis: Microbial metabolites and bile acid changes can influence hepatic insulin sensitivity and lipid handling, affecting triglycerides, HDL, and blood pressure risk through systemic metabolic pathways.

Metabolic syndrome with prediabetes is strongly connected to gut microbiome changes because the same processes that drive insulin resistance—like low-grade inflammation and altered metabolic signaling—can be influenced by microbial composition. When the gut ecosystem shifts toward dysbiosis, it can promote inflammatory pathways (for example, via immune signaling and endotoxin-related mechanisms) that interfere with insulin receptor function. Over time, this can raise fasting glucose and contribute to higher HbA1c by impairing how efficiently the body clears glucose from the bloodstream.

Diet patterns that reduce microbial diversity—often lower fiber intake and higher consumption of ultra-processed foods—also change the metabolites the microbiome produces. Fiber normally feeds beneficial bacteria that ferment it into short-chain fatty acids (SCFAs) such as butyrate, acetate, and propionate. SCFAs support gut barrier integrity, help regulate immune responses, and improve insulin sensitivity; when SCFA production falls, the gut barrier can weaken and systemic inflammation may increase. Dysbiosis can further worsen “leaky gut” by disrupting tight junctions and the protective mucus layer, allowing microbial components to enter circulation more easily and sustaining chronic metabolic inflammation.

Gut microbes also affect bile acid profiles, which act as metabolic hormones through receptors like FXR and TGR5. By modifying bile acids, an unfavorable microbiome can change these signaling pathways that regulate glucose handling, energy metabolism, and inflammatory tone—thereby worsening prediabetes-related glucose control and cardiometabolic risk markers. In addition, shifts in microbial metabolic pathways can influence how the body harvests energy and processes key metabolites, contributing to central fat gain and dyslipidemia. Together, these gut–liver–metabolic axis effects link dysbiosis to insulin resistance and abnormal blood pressure and lipid patterns seen in metabolic syndrome.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes
innerbuddies gut microbiome testing

Microbial patterns summary

In metabolic syndrome with prediabetes, a common microbial pattern is reduced gut microbial diversity alongside an imbalance in taxa toward species that are less efficient at producing protective metabolites. This “dysbiotic” ecosystem is often accompanied by a functional shift away from fiber fermentation, with lower generation of short-chain fatty acids (SCFAs) such as butyrate, acetate, and propionate. Because SCFAs help maintain the gut barrier, tune immune signaling, and support insulin sensitivity, diminished SCFA output can contribute to a low-grade inflammatory state that worsens glucose regulation and promotes higher fasting glucose and HbA1c over time.

Another typical feature is impaired gut barrier function driven by microbiome-associated inflammation. When microbial composition and metabolic activity change, the gut’s mucus layer and tight junction integrity may weaken, increasing intestinal permeability. This can allow microbial products (for example, endotoxin components) to reach circulation more easily, sustaining chronic, subtle inflammation that interferes with insulin receptor signaling and glucose disposal. In parallel, dysbiosis may shift microbial fermentation patterns, altering how nutrients are processed and how inflammatory mediators are produced, reinforcing the metabolic defects characteristic of prediabetes.

Finally, gut microbial alterations frequently extend to bile acid metabolism, creating an unfavorable bile acid profile that affects metabolic signaling. Microbes reshape bile acids into forms that interact with receptors such as FXR and TGR5, which influence glucose handling, energy expenditure, and inflammatory tone. Dysbiosis can therefore disrupt bile acid signaling in ways that worsen insulin resistance and cardiometabolic risk markers, including lipid abnormalities and changes in blood pressure regulation. Diet-driven changes that reduce microbial diversity—particularly low fiber intake and higher ultra-processed food consumption—often amplify these patterns by limiting microbial substrates needed for beneficial metabolite production and balanced host–microbe signaling.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Eubacterium rectale (including E. rectale / related clades)
  • Anaerostipes spp.
  • Akkermansia muciniphila
  • Bifidobacterium spp.
  • Coprococcus spp.
  • Bacteroides uniformis (SCFA-supportive Bacteroides subsets)


Elevated / overrepresented taxa

  • Enterococcus spp.
  • Streptococcus spp.
  • Escherichia-Shigella
  • Klebsiella spp.
  • Bilophila wadsworthia
  • Alistipes spp.
  • Parabacteroides spp.
  • Desulfovibrio spp.


Functional pathways involved

  • Short-chain fatty acid (SCFA) biosynthesis from dietary fiber (butyrate/acetate/propionate production)
  • Butyrate and other SCFA-mediated gut barrier integrity and tight-junction signaling
  • Microbial endotoxin (LPS) generation and lipopolysaccharide-mediated inflammatory signaling (e.g., TLR4/NF-κB)
  • Bile acid synthesis, modification, and secondary bile acid metabolism (FXR/TGR5 signaling axis)
  • Glucose metabolism-linked microbial fermentation and carbohydrate utilization pathways (including reduced fiber fermentation)
  • Branched-chain amino acid (BCAA) metabolism and branched-chain amino acid–associated insulin resistance signaling
  • Gut microbial modulation of host immune signaling and inflammatory mediator production (pro-/anti-inflammatory balance)


Diversity note

In metabolic syndrome with prediabetes, researchers often observe reduced gut microbial diversity alongside a shift in relative abundance toward taxa that are less effective at producing protective metabolites. This “dysbiotic” pattern is frequently accompanied by a functional decline in fiber fermentation, which can translate into lower generation of short-chain fatty acids (SCFAs) such as butyrate, acetate, and propionate. Because SCFAs support gut barrier integrity, help regulate immune tone, and improve insulin sensitivity, a reduction in both diversity and SCFA output can contribute to worsening glucose control over time.

Dysbiosis in this context is also commonly linked to impaired gut barrier function. With altered microbial composition and metabolic activity, the mucus layer and tight junctions may become less robust, increasing intestinal permeability. This can allow microbial-associated components to reach circulation more readily and sustain low-grade inflammation, which can interfere with insulin signaling pathways and promote higher fasting glucose and HbA1c.

Finally, the microbiome’s influence on bile acid metabolism often shifts unfavorably in prediabetes. Changes in microbial communities can alter bile acid profiles and the balance of bile acids that interact with receptors such as FXR and TGR5—pathways involved in glucose handling, energy expenditure, and inflammatory regulation. Diet patterns that reduce microbial diversity (e.g., lower fiber intake and more ultra-processed foods) can further amplify these effects by limiting substrates needed for beneficial microbial functions.


Get Your Gut Microbiome Test Get Your Gut Microbiome Test for Prediabetes

Why generic solutions fail

  • Issue with generic solutions

    For metabolic syndrome with prediabetes, generic gut-focused advice often fails because it treats “microbiome support” as one-size-fits-all rather than as an ecosystem problem driven by underlying insulin resistance, low-grade inflammation, and altered bile acid signaling. If the diet pattern doesn’t change—especially low fiber intake and high ultra-processed food consumption—any probiotic or prebiotic picked at random may not have the right substrates or signals to thrive. Without consistent fiber fermentation inputs, beneficial microbes and their metabolites (notably short-chain fatty acids like butyrate, acetate, and propionate) tend to remain low, leaving gut barrier support, immune modulation, and insulin sensitivity insufficiently improved.

    Generic supplementation also often overlooks the “functional” dimension of dysbiosis. Many interventions claim to “increase good bacteria,” but if they don’t restore metabolite output or gut barrier integrity, the downstream metabolic signaling that matters for HbA1c and fasting glucose may not shift. In prediabetes, gut barrier weakening and immune activation can perpetuate insulin resistance through increased exposure to microbial-derived inflammatory triggers. Without addressing the drivers of permeability (diet quality, meal patterns, and overall inflammatory load), generic fixes can underperform or provide only transient changes.

    Finally, bile acid remodeling is frequently missed in broad-brush approaches. Gut microbes reshape bile acids into receptor-active forms that influence glucose handling via pathways like FXR and TGR5. Generic strategies that don’t meaningfully alter microbial composition and bile acid fermentation capacity may fail to correct the unfavorable bile acid profile that contributes to dysregulated blood sugar, lipid abnormalities, and cardiometabolic risk. In practice, lasting improvement usually requires coordinated diet changes that rebuild microbial diversity and metabolite signaling, rather than isolated probiotic or single-nutrient tactics.

  • Common mistakes

    • Treating the microbiome as a generic target (e.g., “add probiotics/prebiotics”) without changing the underlying diet pattern that drives low microbial diversity and low SCFA production in prediabetes.
    • Choosing supplements without ensuring the right “substrate input” (especially fiber) needed for beneficial microbes to ferment and generate SCFAs (butyrate, acetate, propionate); this can leave metabolite output too low to meaningfully improve insulin sensitivity and barrier function.
    • Focusing only on composition (more “good bacteria”) while ignoring functional outcomes like SCFA signaling, gut barrier integrity, and reduced inflammatory metabolite/endotoxin exposure—so HbA1c and fasting glucose may not improve.
    • Overlooking gut barrier/permeability drivers (diet quality, inflammatory load, meal patterns); failing to address permeability can perpetuate chronic low-grade inflammation that worsens insulin receptor signaling.
    • Missing bile acid remodeling as a key mechanism (microbe-driven bile acid forms that signal via FXR/TGR5); generic strategies may not shift bile acid profiles in a way that improves glucose handling and cardiometabolic risk.
    • Using ultra-processed or low-fiber diets as “constant background,” which can blunt the effect of any probiotic/prebiotic by not providing fermentable substrates or by sustaining dysbiosis.
    • Relying on short-term interventions and expecting durable metabolic improvements without sustained dietary and lifestyle changes to rebuild microbial diversity and metabolite pathways.
    • Selecting products based on marketing/popularity rather than compatibility with the person’s likely functional deficits (low SCFAs, barrier issues, altered bile acid metabolism), leading to mismatched or underwhelming effects.

What to do

  • General support strategies

    For metabolic syndrome with prediabetes, a core strategy is to support gut microbial balance by improving diet quality—especially by increasing dietary fiber from minimally processed foods. A fiber-rich pattern (vegetables, legumes, whole grains, nuts, and seeds) helps promote microbial diversity and boosts the production of short-chain fatty acids (SCFAs), which help strengthen the gut barrier, reduce low-grade inflammation, and support better insulin sensitivity. When the diet shifts away from highly processed, low-fiber choices, the gut ecosystem is more likely to favor beneficial bacteria that contribute to healthier glucose regulation and cardiometabolic signaling.

    Because gut integrity and immune activation are tightly linked to metabolic health, it also helps to focus on strategies that reduce inflammatory gut stress and restore gut barrier function. This often means emphasizing regular, high-fiber meals and including prebiotic fibers (such as inulin- or fructooligosaccharide-type fibers) if tolerated, which act as fuel for SCFA-producing microbes. For some people, fermented foods or probiotic-containing options (including fermented dairy or suitable alternatives) may further support a more favorable microbial community and metabolite profile, though responses can vary by individual and baseline microbiome.

    Another important angle is bile acid signaling, since gut microbes help convert and regulate bile acids that influence glucose handling and inflammation through receptors like FXR and TGR5. Eating a pattern that encourages healthier microbial function—generally via fiber diversity rather than restrictive approaches—can support more beneficial bile acid profiles. Over time, these gut-driven changes in SCFAs and bile acid metabolites may help improve fasting glucose, HbA1c, triglycerides, and HDL, while also supporting broader metabolic risk factors such as blood pressure.

  • Lifestyle recommendations

    • Prioritize a fiber-rich, minimally processed eating pattern (vegetables, legumes, whole grains, nuts, seeds) to support SCFA production and gut barrier health.
    • Reduce ultra-processed foods and added sugars (especially sugary drinks and refined starches) to lower glycemic burden and gut dysbiosis risk.
    • Aim for regular physical activity (e.g., aerobic + resistance training most weeks) to improve insulin sensitivity and reduce low-grade inflammation.
    • Include prebiotic and fermented foods if tolerated (e.g., legumes, onions/garlic, oats; yogurt/kefir or unsweetened fermented alternatives) to enhance microbial diversity.
    • Maintain a gradual, sustainable weight-loss goal if overweight (even 5–10% can improve insulin resistance and cardiometabolic markers).
    • Manage sleep and stress (consistent sleep schedule, stress-reduction practices like mindfulness or breathing) to support glucose regulation and reduce inflammatory signaling.

  • Nutrition recommendations

    • Prioritize a high-fiber, minimally processed eating pattern: aim for plenty of non-starchy vegetables, legumes (beans/lentils), whole grains, nuts, and seeds to support SCFA production and improve insulin sensitivity.
    • Increase soluble fiber specifically (target ~5–10 g/day increase): foods like oats, barley, chia, ground flax, beans, lentils, and many fruits (e.g., berries, apples) can improve post-meal glucose and feed beneficial gut microbes.
    • Reduce ultra-processed foods and added sugars: limit sugary drinks, sweets, refined carbs, and fast/packaged snacks to decrease dysbiosis and help lower fasting glucose and HbA1c.
    • Use prebiotic foods and/or prebiotic supplements if tolerated: consider psyllium husk and/or inulin/FOS (start low and increase) to enhance microbial diversity and improve gut barrier function.
    • Add fermented foods regularly if tolerated: include unsweetened yogurt/kefir, fermented vegetables (sauerkraut/kimchi), and other minimally sweet fermented options to promote beneficial microbial activity.
    • Choose healthy fats that support cardiometabolic markers: emphasize extra-virgin olive oil, avocado, nuts, and fatty fish; limit trans fats and excess saturated fat which can worsen inflammation and lipid profiles.
    • Support bile acid–metabolic signaling via diet: maintain fiber diversity (mix of soluble + insoluble sources) and limit low-fiber, high-fat processed foods that can shift bile acid pools in less favorable directions.

  • Supplement considerations

    For metabolic syndrome with prediabetes, gut-targeted supplements are often considered because insulin resistance and low-grade inflammation are tightly connected to microbial composition, gut barrier integrity, and bile-acid signaling. Supporting a healthier microbiome may help reduce inflammatory tone that can impair glucose handling. In practice, this typically focuses on fibers (as prebiotics) that promote beneficial taxa and improve gut barrier function, alongside adjuncts that may influence bile-acid pathways involved in glucose regulation and energy metabolism.

    Prebiotic and fiber-based supplements are usually foundational when diet fiber is insufficient. By feeding microbes that generate short-chain fatty acids (SCFAs), these options can support the gut lining, modulate immune signaling, and improve insulin sensitivity. Look for supplemental fibers with evidence for metabolic benefit (such as inulin-type prebiotics, partially hydrolyzed guar gum, or resistant starch), and consider gradual titration to minimize gas and bloating. If you’re also dealing with dysbiosis-associated symptoms or irregular bowel habits, additional strategies like fermented foods or probiotic formulations may be considered—though the most appropriate strains and dosing can vary by person.

    Because bile acids can act as metabolic signals through receptors like FXR and TGR5, some supplement approaches aim to improve bile-acid composition and downstream cardiometabolic markers. In addition, targeted nutrients may be relevant if deficiencies are present, since micronutrient status can influence glucose metabolism and inflammatory pathways. It’s also important to coordinate supplement choices with overall carbohydrate quality, portion size, and body-weight goals, since the gut-microbe benefits from supplements tend to be strongest when paired with minimally processed, fiber-rich eating patterns.

  • Retesting / monitoring note

    For metabolic syndrome with prediabetes, retesting is typically done after a structured gut- and lifestyle-focused intervention has had enough time to shift microbiome function and downstream metabolic signaling. A common approach is to reassess cardiometabolic markers at about 8–12 weeks, since dietary fiber intake, microbial fermentation (including short-chain fatty acid production), and gut barrier–related inflammation markers can change measurably within that window. If you’re also using a structured nutrition plan or adding prebiotic/fermented foods, retesting sooner (around 6–8 weeks) may still be informative, but confirm with a standard interval to capture more stable trends.

    The most useful retesting targets are the biomarkers that reflect glucose regulation and insulin resistance, such as fasting glucose, HbA1c, and—when appropriate—fasting insulin and/or a HOMA-IR calculation. Because gut-driven changes often influence inflammation and lipid handling as well, many clinicians also recheck a lipid panel (triglycerides and HDL in particular) and, depending on your baseline risk, blood pressure and waist circumference. If bile acid signaling and gut-derived inflammation are a known focus, you may also discuss whether additional labs (selected inflammatory markers or other clinician-chosen metabolic indicators) are warranted for your situation.

    If results improve, retesting intervals can be extended (for example, every 3–6 months) to ensure the gains are sustained and not just short-term fluctuations. If results are unchanged or worsen, that’s a cue to review diet adherence, fiber diversity and tolerance (including gradual increases of prebiotic fibers), and overall gut ecosystem factors such as sleep, stress, and medication use that can affect microbiome composition. In practice, retesting should be paired with a clear action plan—refining fiber sources (vegetables, legumes, whole grains, nuts, seeds), emphasizing minimally processed foods, and supporting microbial metabolite production—so the next set of labs tests a meaningful change in the gut-metabolic pathway.

The importance of gut microbiome testing

  • Why testing matters

    For people with metabolic syndrome and prediabetes, gut microbiome testing can matter because the gut ecosystem is not just a bystander to insulin resistance—it can help shape the inflammatory signals and metabolic pathways that influence fasting glucose and HbA1c. By revealing patterns associated with dysbiosis (such as reduced beneficial diversity or shifts in bacteria involved in carbohydrate and fiber processing), testing can help explain why glucose regulation may be trending upward even when calorie intake feels stable. Since low-grade inflammation and gut-barrier changes are common in this condition, microbiome data may provide clues about whether the gut environment is more likely to promote metabolic inflammation.

    Microbiome results are also useful for connecting diet, microbial metabolites, and cardiometabolic risk. Many protective gut microbes produce short-chain fatty acids (SCFAs) from dietary fiber, which support gut barrier integrity, modulate immune signaling, and improve insulin sensitivity. Testing can highlight whether your current microbial functions suggest lower SCFA production potential—often seen with low fiber intake and higher ultra-processed foods—so you can tailor fiber type and amounts more strategically (rather than guessing). In parallel, microbiome profiles can offer insight into fermentation balance and how closely your gut ecology aligns with better triglycerides, HDL, and overall energy metabolism.

    Finally, bile acids are a major “gut-to-metabolism” signaling link, and microbiome testing can help you understand how your gut community may be influencing bile acid composition and signaling through receptors like FXR and TGR5. Because these pathways affect glucose handling, inflammation, and energy use, gut-driven bile acid shifts may contribute to prediabetes progression and broader cardiometabolic markers such as lipids and blood pressure. With this context, testing can support more personalized nutrition choices—such as which prebiotic fibers or fermented options are likely to be better tolerated and more effective for your specific microbiome function—helping move the system toward a healthier, more metabolically supportive gut environment.

  • How InnerBuddies helps

    InnerBuddies can help people with metabolic syndrome and prediabetes by characterizing gut microbiome patterns that are commonly linked to insulin resistance, low-grade inflammation, and gut-barrier stress. Since dysbiosis can influence how the body responds to carbohydrates and can sustain inflammatory signaling that drives higher fasting glucose and HbA1c, microbiome results provide a practical “starting map” for identifying whether your current gut ecosystem looks more like a metabolically supportive community or a less favorable one. This can help explain why glucose regulation may be trending upward even when lifestyle changes alone feel insufficient.

    The test can also support more targeted nutrition decisions by highlighting gut microbes and functional tendencies related to fiber fermentation and short-chain fatty acid (SCFA) production—key metabolites that help strengthen the gut barrier, modulate immune signaling, and improve insulin sensitivity. When microbiome outputs suggest lower capacity for beneficial fermentation (often seen with low fiber diversity and higher ultra-processed food intake), InnerBuddies can guide how to adjust fiber type, variety, and timing so you’re not relying on guesswork. In parallel, the results may offer clues about fermentation balance that aligns with cardiometabolic markers such as triglycerides and HDL.

    Finally, because gut microbes shape bile acid profiles—important metabolic signals that act through receptors like FXR and TGR5—InnerBuddies can help connect your microbial ecosystem to glucose handling and broader cardiometabolic risk. By understanding whether your microbiome appears likely to influence bile acid composition and signaling in a way that affects inflammation and energy metabolism, you can refine your gut-focused approach (including prebiotic fibers and, when tolerated, fermented foods) to better support metabolic health and prediabetes progression.

Medical Evidence

  • Scientific evidence level

    3 [moderate (moderately supported) for association and plausible mechanisms; low for clinical utility and intervention effectiveness]

  • Clinical relevance note

    2) **Biological plausibility & mechanisms (supporting but not definitive):** There are credible pathways linking the gut microbiome to insulin sensitivity and metabolic syndrome biology, including: altered short-chain fatty acid (SCFA) production (e.g., butyrate/propionate) affecting host energy metabolism and GLP-1/PYY signaling; bile acid transformations influencing FXR/TGR5 pathways; microbiome-driven modulation of intestinal barrier function and endotoxin (LPS) signaling; microbial metabolites affecting inflammation and hepatic lipid metabolism; and differences in microbial fermentation/host-microbial nutrient cross-talk. These mechanisms provide **plausibility** for a causal role, but they do not establish directionality in humans (prediabetes could also reshape the microbiome through diet, inflammation, medications, glycemic milieu, and adiposity).

Title Journal Year Link
Gut microbiome and body weight: evidence from human studies Nature Reviews Endocrinology 2018 View →
Metformin alters the gut microbiome of patients with type 2 diabetes and improves insulin sensitivity Nature Medicine 2017 View →
Gut microbiota in prediabetes and type 2 diabetes: a systematic review and meta-analysis Diabetes/Metabolism Research and Reviews 2017 View →
Microbiota composition is associated with insulin resistance and T2D risk in humans Diabetes 2012 View →
Intestinal microbiota in patients with obesity and type 2 diabetes mellitus Nature 2005 View →

Frequently Asked Questions

    Qu'est-ce que le syndrome métabolique avec prédiabète et pourquoi est-ce important ?
    C’est un ensemble de facteurs de risque (glycémie élevée, graisse abdominale, lipides anormaux, tension artérielle élevée) qui augmentent le risque de diabète de type 2 et de maladies cardiovasculaires. Des stratégies de mode de vie et de santé intestinale peuvent réduire ce risque.
    Comment le microbiote intestinal influence-t-il la glycémie et la résistance à l’insuline ?
    Il peut affecter l’inflammation, la barrière intestinale, l’extraction d’énergie et la signalisation des acides biliaires, ce qui peut influencer le contrôle de la glycémie.
    Qu’est-ce que la dysbiose et comment pourrait-elle être liée à la prédiabète ?
    La dysbiose est un déséquilibre du microbiote; elle peut favoriser l’insulino-résistance et l’inflammation chronique liées à la régulation de la glycémie.
    Que montrent les tests du microbiome et comment les utiliser ?
    Ils donnent le profil des microbes, leur diversité et des voies métaboliques; ils peuvent guider des choix alimentaires et la compréhension de l’inflammation ou du signal des acides biliaires.
    Qu’est-ce que les acides gras à chaîne courte (SCFA) et pourquoi sont-ils importants ?
    Produits par la fermentation des fibres; ils renforcent la barrière intestinale, régulent les signaux immunitaires et améliorent la sensibilité à l’insuline.
    Comment l’alimentation peut-elle influencer le microbiote et le risque de prédiabète ?
    Plus de fibres variées et moins d’aliments ultra-transformés favorisent une diversité microbienne et des métabolites bénéfiques.
    Quels aliments sont bons pour la santé intestinale et le contrôle glycémique ?
    Légumes non féculents, légumineuses, céréales complètes, noix/graines et une variété de fibres; options fermentées si tolérées; limiter les aliments ultra-transformés.
    Le test du microbiome peut-il guider mon régime ou mes choix de fibres ?
    Il peut donner des indices sur les types et quantités de fibres qui soutiennent votre gut et votre glycémie; ce n’est pas une solution unique; discutez des résultats avec un professionnel.
    Quel est le rôle des acides biliaires dans le métabolisme et comment le microbiome peut-il les influencer ?
    Les acides biliaires agissent comme des signaux métaboliques; le microbiome peut modifier leur composition, influençant la régulation de la glycémie et l’inflammation.
    Les probiotiques ou prébiotiques sont-ils recommandés pour la prédiabète ?
    Ils peuvent aider certaines personnes, mais les preuves varient; privilégier l’alimentation et discuter des compléments avec un professionnel.
    Combien de changements de mode de vie faut-il pour impacter le risque ?
    Activité physique régulière, gestion du poids, sommeil suffisant et limitation de l’alcool et des sucres ajoutés améliorent l’insulinosensibilité avec le temps.
    Que faire avant et après un test du microbiome comme InnerBuddies ?
    Planifiez avec un professionnel de santé, apportez votre histoire médicale, suivez les instructions du test et interprétez les résultats dans le cadre global de votre prise en charge.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -